You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 201361 - 201370 of 204843 results
  1. Developing and Scaling an interactive text messaging tool to help pregnantsmoker

    SBC: Voxiva, Inc            Topic: NIDA

    DESCRIPTION (provided by applicant): There is no more important target audience for smoking cessation efforts than pregnant women. The goal of this Fast Track project is to establish the scientific and technical feasibility of using an interactive text- and web-based application to support smoking cessation among pregnant women. This project aims to develop the first-ever text message based smokin ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  2. Virtual Environment Training in the Proper Use of Prescription Pain Medications

    SBC: Clinical Tools, Inc            Topic: NIDA

    DESCRIPTION: (provided by applicant) An epidemic of addiction to prescription pain medications now causes deaths due to overdose that outnumber automobile-related deaths, rising admissions to hospitals, and disrupted lives for both the patient and family.The White House Office of National Drug Control Policy (ONDCP) report, Epidemic: Responding to America's Prescription Drug Abuse Crisis, hig ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  3. Development of an Intraoral Optical Probe for the Microscopic Evaluation of Denta

    SBC: AVANTGEN INC            Topic: NIDA

    DESCRIPTION (provided by applicant): The development of addiction involves the dopaminergic reward pathway and downstream negative changes that lead to craving and repeat self-administration. While it is clear this process involves changes in neuronal plasticity t the synapse junction, the exact changes at the protein level leading to the development of dependence and negative responses associated ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  4. Novel Ultra-Flexible Hybrid Circuits for Intraocular Retinal Prostheses

    SBC: ETECT, INC.            Topic: NIDA

    DESCRIPTION (provided by applicant): Poor medication adherence has a significant negative impact on patients, clinical study outcomes, and the healthcare system in general. As much as 25% of all healthcare costs could be avoided if patients reliably took their prescribed medications. Medication adherence is of particular concern in clinical trials. Standard measures of adherence (pill counting and ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  5. Point-of-Care Nucleic Acid Test for Cytomegalovirus for Newborn Hearing Screening

    SBC: ADVANCED LIQUID LOGIC            Topic: NIDCD

    DESCRIPTION (provided by applicant): Universal newborn hearing screening is mandated in the US and is performed in the postpartum hospital setting. Current physiology-based hearing screening tests are unable to detect late-onset hearing loss caused by cytomegalovirus (CMV) infection. Therefore, a complementary screening approach has been suggested to prevent disabilities associated with CMV-relate ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  6. Pb-Qdot Direct Gamma Detectors

    SBC: EAR MACHINE, LLC            Topic: NIDCD

    DESCRIPTION (provided by applicant): Finding the signal processing parameter values that are most appropriate for an individual patient is one of the essential components of hearing aid fitting. In common practice, the hearing aid user only plays a small role in selecting these values. This proposal describes a data-driven method for empowering users to select their desired parameter values by adj ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  7. Clinical Development of a Therapeutic Agent for COPD

    SBC: PHOTOZIG INC            Topic: NIDCD

    DESCRIPTION (provided by applicant): Noise-induced hearing loss (NIHL) is the second most common form of hearing deficit, affecting about 26 million American adults. In addition, about one in eight children have NIHL in the US (~5.2 million children), andit is estimated that 20% of US adolescents have hearing loss. We propose the development of a social game to educate teenagers about NIHL, and pr ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Discovery of Anti-HBV cccDNA Compounds from a Unique Natural Products Collection

    SBC: KDH Research & Communication, Inc.            Topic: NIDCR

    DESCRIPTION (provided by applicant): KDH Research and Communication (KDHRC) proposes to develop and evaluate Dientes Fuertes, Vida Sana (DFVS), a culturally-competent program to prevent primary tooth decay in low-income Latino children ages zero to six. Toeffectively reach low-income Latino children, DFVS will train promotores de salud (PS) at Latino-serving community-based organizations (CBOs) to ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  9. Development of an Electromyographically Controlled Electrolarynx Voice Prosthesis

    SBC: Xeris Pharmaceuticals, Inc.            Topic: NIDDK

    DESCRIPTION (provided by applicant): The program outlined in this application has been designed to accelerate the development and commercialization of a Glucagon Mini-Dose Pen to change the paradigm for treatment of moderate hypoglycemia in insulin-using diabetics. This research is directly relevant to the NIDDK which is explicitly interested in the development of innovative technologies for the p ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  10. DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease

    SBC: DISCOVERYBIOMED, INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): An important discovery and validation event occurred recently within human cell-based drug discovery programs at DiscoveryBioMed, Inc. (DBM), yielding a lead class of cytostatic anti-proliferative small molecules thatdisplay nanomolar potency and marked efficacy against hyperproliferative human PKD cells that create and line remodeled PKD cysts within emergent ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government